Two Sigma Investments’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q1 | – | Sell |
-344,781
| Closed | -$2.08M | – | 2651 |
|
2019
Q4 | $2.08M | Sell |
344,781
-331,907
| -49% | -$2M | 0.01% | 1084 |
|
2019
Q3 | $2.44M | Buy |
676,688
+144,657
| +27% | +$521K | 0.01% | 857 |
|
2019
Q2 | $1.43M | Buy |
532,031
+176,294
| +50% | +$473K | ﹤0.01% | 1222 |
|
2019
Q1 | $1.05M | Sell |
355,737
-815,959
| -70% | -$2.42M | ﹤0.01% | 1404 |
|
2018
Q4 | $1.86M | Buy |
1,171,696
+1,122,993
| +2,306% | +$1.79M | 0.01% | 1067 |
|
2018
Q3 | $179K | Sell |
48,703
-126,519
| -72% | -$465K | ﹤0.01% | 1880 |
|
2018
Q2 | $496K | Buy |
+175,222
| New | +$496K | ﹤0.01% | 1636 |
|
2018
Q1 | – | Sell |
-1,107,595
| Closed | -$3.19M | – | 2537 |
|
2017
Q4 | $3.19M | Buy |
+1,107,595
| New | +$3.19M | 0.01% | 955 |
|
2017
Q1 | – | Sell |
-383,676
| Closed | -$1.59M | – | 2557 |
|
2016
Q4 | $1.59M | Buy |
383,676
+258,289
| +206% | +$1.07M | 0.01% | 1268 |
|
2016
Q3 | $1.02M | Buy |
125,387
+112,934
| +907% | +$915K | ﹤0.01% | 1316 |
|
2016
Q2 | $97K | Sell |
12,453
-7,447
| -37% | -$58K | ﹤0.01% | 1938 |
|
2016
Q1 | $154K | Sell |
19,900
-17,600
| -47% | -$136K | ﹤0.01% | 1952 |
|
2015
Q4 | $405K | Buy |
+37,500
| New | +$405K | ﹤0.01% | 1617 |
|
2014
Q4 | – | Sell |
-546,672
| Closed | -$5.46M | – | 2458 |
|
2014
Q3 | $5.46M | Buy |
546,672
+456,223
| +504% | +$4.55M | 0.02% | 599 |
|
2014
Q2 | $685K | Buy |
+90,449
| New | +$685K | ﹤0.01% | 1474 |
|